1,251 results on '"Hogan, William J."'
Search Results
2. The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
3. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD
4. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis
5. Long-term outcomes of allogeneic stem cell transplant in multiple myeloma
6. Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events
7. Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
8. An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
9. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
10. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD
11. Effective treatment of low-risk acute GVHD with itacitinib monotherapy
12. Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioning
13. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification
14. Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms
15. Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent
16. Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis
17. Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms
18. Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms
19. Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation
20. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
21. Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia
22. Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation
23. Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases
24. Comparison of Pretransplantation Prediction Models for Nonrelapse Mortality in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation
25. Pericardial Effusion as a Purported Manifestation of Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation
26. Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths
27. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
28. Allogeneic Hematopoietic Stem Cell Transplantation in the Outpatient Setting: The Mayo Clinic Experience
29. Risk Factors and Outcomes of Nocardiosis in Hematopoietic Stem Cell Transplantation Recipients
30. Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes
31. Impact of hospital hospitality house programs on quality of life and mood of patients and caregivers after hematopoietic stem cell transplant
32. Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved
33. Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant
34. Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases.
35. Mast cell cytomorphology and treatment outcome in mast cell leukemia.
36. Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.
37. Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases
38. The utility of biomarkers in acute GVHD prognostication
39. Long-Term Pulmonary Function Trajectories After Allogeneic Bone Marrow Transplantation
40. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions
41. Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
42. Mayo Clinic experience with 1123 adults with acute myeloid leukemia
43. Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure
44. Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma
45. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
46. Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia
47. Experience With an Optical Character Recognition Search Application for Review of Outside Medical Records
48. Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience
49. Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease
50. Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk Cytogenetics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.